in cooperation with the CMMC, IPHS, CCRC Program and SFB 829
Precision medicine: concepts and targets
Roman Thomas, Translational Genomics
Towards precision medicine in neuroblastoma
Matthias Fischer, Dept. Children and Adolescent Medicine
Hereditary breast- and ovarian cancer: New genes and new concepts for individual risk prediction
Eric Hahnen, Center for Familial Breast and Ovarian Cancer
Targeting molecular vulnerabilities in cancer
Martin Sos, Institute Pathology
RNA therapeutics for neuromuscular disorders by splice switching antisense oligonucleotides
Sebahattin Cirak, Dept. Pediatrics and Adolescent Medicine
Principles of high throughput screening in drug discovery
Jan Rybniker, Department I Internal Medicine
Targeting the DNA damage response for precision cancer therapy
Christian Reinhardt, Department I Internal Medicine
Tumor-microenvironment dependent therapy response in B-cell lymphoma
Christian Pallasch, Department I Internal Medicine
BCL2: one target for all malignancies?
Lukas Frenzel, Department I Internal Medicine
Spinal muscular atrophy: from gene and modifiers to therapy
Brunhilde Wirth, Institute Human Genetics
Further information: Catherin Niemann (cnieman1(at)uni-koeln.de)